182 related articles for article (PubMed ID: 3496779)
1. Effects on hemodynamics and left ventricular ejection fraction of intravenous bepridil for impaired left ventricular function secondary to coronary artery disease.
Josephson MA; Mody T; Coyle K; Singh BN
Am J Cardiol; 1987 Jul; 60(1):44-9. PubMed ID: 3496779
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of intravenous bepridil in patients with normal left ventricular function.
Alpert JS; Benotti JR; Brady PM; McCue JE; Weiner BH; Ockene IS
Am J Cardiol; 1985 Mar; 55(7):20C-24C. PubMed ID: 3872053
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic assessment of intravenous bepridil administration in ischemic heart disease.
Tamari I; Borer JS; Moses JW; Goldberg HL; Fisher J; Wallis JB; Halle A
Am J Cardiol; 1985 Mar; 55(7):25C-29C. PubMed ID: 3872054
[TBL] [Abstract][Full Text] [Related]
4. Acute hemodynamic and antiischemic properties of intravenous bepridil in coronary artery disease.
Remme WJ; Kruyssen DA; Van Hoogenhuyze DC; Hofman B; Krauss XH; Storm CJ
Am J Cardiol; 1989 Mar; 63(11):670-5. PubMed ID: 2784281
[TBL] [Abstract][Full Text] [Related]
5. Dose related coronary and systemic haemodynamic effects of intravenous bepridil in patients with coronary artery disease.
Remme WJ; van Hoogenhuyze DC; Krauss XH; Hofman A; Storm CJ; Kruyssen HA
Eur Heart J; 1987 Feb; 8(2):130-40. PubMed ID: 3494607
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of intravenous diltiazem with impaired left ventricular function.
Materne P; Legrand V; Vandormael M; Collignon P; Kulbertus HE
Am J Cardiol; 1984 Oct; 54(7):733-7. PubMed ID: 6486022
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic actions of bepridil during treatment of stable angina pectoris.
Narahara KA; Shapiro W; Weliky I; Park J
Am J Cardiol; 1985 Mar; 55(7):55C-58C. PubMed ID: 3883742
[TBL] [Abstract][Full Text] [Related]
8. [Hemodynamic effects of a new calcium antagonist, bepridil, in patients with coronary artery disease].
Haerer VW; Stauch M
Arzneimittelforschung; 1987 Jul; 37(7):829-31. PubMed ID: 3499908
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of calcium-channel blocking agents on left ventricular function during acute ischemia in dogs with and without congestive heart failure.
Urquhart J; Epstein SE; Patterson RE
Am J Cardiol; 1985 Jan; 55(3):10B-16B. PubMed ID: 3969856
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravenous N-acetylprocainamide on hemodynamics and left ventricular function in man.
Josephson MA; Schwab M; Coyle K; Singh BN
Am Heart J; 1987 Apr; 113(4):952-7. PubMed ID: 2436466
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of a new calcium antagonist, SR 33557, in patients with coronary artery disease and normal left ventricular function.
Saal JP; Lellouche D; Habbal R; Sissmann J; Castaigne A; Dubois-Randé JL
J Cardiovasc Pharmacol; 1994 Jan; 23(1):87-91. PubMed ID: 7511741
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of bepridil in patients with coronary artery disease.
Narahara KA
Am J Cardiol; 1992 Apr; 69(11):17D-24D. PubMed ID: 1553887
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease.
Josephson MA; Kaul S; Hopkins J; Kvam D; Singh BN
Am Heart J; 1985 Jan; 109(1):41-5. PubMed ID: 3966331
[TBL] [Abstract][Full Text] [Related]
14. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
[TBL] [Abstract][Full Text] [Related]
15. Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease.
Pouleur H; Etienne J; Van Mechelen H; Van Eyll C; Charlier AA; Brasseur LA; Rousseau MF
Postgrad Med J; 1984; 60 Suppl 4():23-8. PubMed ID: 6527976
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic, hemodynamic and metabolic effects of intravenous bepridil hydrochloride.
Upward JW; Daly K; Campbell S; Bergman G; Jewitt DE
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1589-95. PubMed ID: 3873868
[TBL] [Abstract][Full Text] [Related]
17. Alterations in contrast medium-induced coronary reactive hyperemia after bepridil in patients with coronary artery disease.
Foult JM; Nitenberg A; Blanchet F; Zouiouèche S; Huyghebaert MF
Am Heart J; 1985 Feb; 109(2):244-51. PubMed ID: 3871297
[TBL] [Abstract][Full Text] [Related]
18. Acute hemodynamic effects of intravenous diperdipine, a new dihydropyridine derivative, in coronary heart disease.
Di Donato M; Maioli M; Venturi F; Bürgisser C; Fantini F; Biamino G; Marchionni N
Am Heart J; 1991 Mar; 121(3 Pt 1):776-81. PubMed ID: 2000744
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of the acute hemodynamic effect of nisoldipine (Bay k 5552) and nifedipine in patients with ischemia-induced left ventricular impaired function].
Aschenberg W; Nienaber C; Spielmann R; Bleifeld W
Z Kardiol; 1988 Apr; 77(4):238-44. PubMed ID: 3291444
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease.
Rousseau MF; Etienne J; Van Mechelen H; Veriter C; Pouleur H
J Cardiovasc Pharmacol; 1984; 6(5):833-9. PubMed ID: 6209488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
